这个股票AMRS的公司已解决了:
Amyris Announces Positive Pre-Clinical Results For COVID-19 RNA Vaccine Platform With Advantaged Manufacturing, Storage And Distribution Characteristics
Amyris 宣布 COVID-19 RNA 疫苗平台的积极临床前结果具有优势的制造、储存和分销特征
https://finance.yahoo.com/news/amyris-announces-positive-pre-clinical-130000222.html
并且它正合作(明年初)推出鼻喷疫苗
Amyris Achieves Promising In-Vivo Results For Intranasal Delivery Of RNA/NLC Vaccine
Amyris 在鼻内递送 RNA/NLC 疫苗方面取得了有希望的体内结果
https://finance.yahoo.com/news/amyris-achieves-promising-vivo-results-120000644.html